p-Hydroxyhippuryl-His-Leu-OH
CAS: 77697-23-5
Ref. 3D-FH110868
1g | 1.810,00 € | ||
50mg | 230,00 € | ||
100mg | 375,00 € | ||
250mg | 666,00 € | ||
500mg | 1.039,00 € |
Produktinformation
- <span class="text-smallcaps">L</smallcap>-Leucine, N-(4-hydroxybenzoyl)glycyl-<smallcap>L</span>-histidyl-
- <span class="text-smallcaps">L</smallcap>-Leucine, N-[N-[N-(4-hydroxybenzoyl)glycyl]-<smallcap>L</span>-histidyl]-
- N-(4-Hydroxybenzoyl)glycyl-<span class="text-smallcaps">L</smallcap>-histidyl-<smallcap>L</span>-leucine
- N-(4-hydroxybenzoyl)glycyl-L-histidyl-L-leucine
- p-Hydroxyhippuryl-<span class="text-smallcaps">L</smallcap>-histidyl-<smallcap>L</span>-leucine
P-hydroxyhippuryl-His-Leu-OH is a natriuretic that has been shown to have beneficial effects on diabetic patients. It can be used to prevent and treat proliferative diabetic retinopathy, which is a complication of diabetes. P-hydroxyhippuryl-His-Leu-OH increases the glomerular filtration rate and decreases the ventricular mass index, which may be due to its ability to inhibit angiotensin II receptors in the brain. P-hydroxyhippuryl-His-Leu-OH also inhibits angiotensin converting enzyme, an enzyme that converts angiotensin I into angiotensin II. This inhibition leads to an increase in levels of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and the downstream effectors of these peptides, namely nitric oxide synthase and cyclooxygenase
Chemische Eigenschaften
Technische Anfrage zu: 3D-FH110868 p-Hydroxyhippuryl-His-Leu-OH
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.